May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Screening for Glaucomatous Optic Nerve Damage: The Los Angeles Latino Eye Study
Author Affiliations & Notes
  • B.A. Francis
    Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • M. Ying–Lai
    Department of Preventive Medicine, Keck School of Medicine at USC, Los Angeles, CA
  • J. Winarko
    Keck School of Medicine, Los Angeles, CA
  • B. Nguyen
    Anahiem Eye Medical Group, Anaheim, CA
  • R. Varma
    Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • Los Angeles Latino Eye Study Group
    Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships  B.A. Francis, None; M. Ying–Lai, None; J. Winarko, None; B. Nguyen, None; R. Varma, None.
  • Footnotes
    Support  NIH Grant EY11753
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 2499. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B.A. Francis, M. Ying–Lai, J. Winarko, B. Nguyen, R. Varma, Los Angeles Latino Eye Study Group; Screening for Glaucomatous Optic Nerve Damage: The Los Angeles Latino Eye Study . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2499.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To evaluate the ability of various glaucoma screening tests to detect glaucomatous optic nerve damage in a population–based sample of Latinos.Methods: The Los Angeles Latino Eye Study (LALES) is a population–based study of eye disease in Latinos aged 40 years and older. Study participants underwent an interview and a clinical examination that included Humphrey visual field testing SITA Standard (HVF) and Frequency Doubling Perimetry (FDP), measurement of intraocular pressure (IOP) and central corneal thickness (CCT), and cup/disc ratio. The gold standard for glaucoma was the presence of a glaucomatous optic nerve appearance by a consensus of three glaucoma specialists. Chi–square analysis and stepwise logistic regression were used to evaluate the ability of the following parameters to detect glaucoma: HVF result, fixation losses (FL>50%), false positives (FP>50%), false negatives (FN>33%), mean deviation (MD, p<5%), pattern standard deviation (PSD, p<5%), abnormal glaucoma hemifield test (GHT), FDP, IOP > 21mmHg, and CCT (<510µ, 510–580, >580). Sensitivity and specificity were calculated for HVF, FN, MD, PSD, GHT, FDP, IOP, CCT, and prior diagnosis of glaucoma. Receiver operating curves were calculated for MD, PSD, and IOP. Results: Sensitivity and specificity were as follows: HVF result = 63.3%, 89.0%, FN = 4.1%, 98.3%, MD = 78.8%, 64.3%, PSD = 66.2%, 77.9%, GHT = 76.0%, 71.6%; FDP = 61.6%, 78.9%, IOP = 18.0%, 97.0%, CCT = 9.6%, 93.8%, and prior diagnosis = 26.5%, 98.0%. The areas under the curve (AUC) were as follows: MD = 0.79, PSD = 0.79, and IOP = 0.72. Conclusions: In this population–based study of Latinos, HVF parameters and FDP parameters had moderate sensitivity and specificity. IOP, CCT and prior diagnosis had poor sensitivity and good specificity. In a population–based screening for glaucomatous optic nerve damage, neither IOP, FDP nor HVF are good screening tests.

Keywords: clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.